{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T03:13:08Z","timestamp":1777432388824,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.virusres.2021.198456","type":"journal-article","created":{"date-parts":[[2021,7,24]],"date-time":"2021-07-24T10:33:32Z","timestamp":1627122812000},"page":"198456","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Stability and antiviral activity of SP40 peptide in human serum"],"prefix":"10.1016","volume":"303","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5007-9891","authenticated-orcid":false,"given":"Faisal","family":"Zarif","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7895-9110","authenticated-orcid":false,"given":"Mohd Ishtiaq","family":"Anasir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia Xuen","family":"Koh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miaw-Fang","family":"Chew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8475-6291","authenticated-orcid":false,"given":"Chit Laa","family":"Poh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.virusres.2021.198456_bib0005","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/01.inf.0000059765.92623.70","article-title":"Double blind placebo-controlled trial of pleconaril in infants with enterovirus meningitis","volume":"22","author":"Abzug","year":"2003","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"4","key":"10.1016\/j.virusres.2021.198456_bib0010","doi-asserted-by":"crossref","DOI":"10.3390\/v12040367","article-title":"Structure-based design of antivirals against envelope glycoprotein of dengue virus","volume":"12","author":"Anasir","year":"2020","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.virusres.2021.198456_bib0015","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12929-021-00708-8","article-title":"Antivirals blocking entry of enteroviruses and therapeutic potential","volume":"28","author":"Anasir","year":"2021","journal-title":"J. Biomed. Sci."},{"issue":"4","key":"10.1016\/j.virusres.2021.198456_bib0020","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1111\/jam.12921","article-title":"Anti-dengue virus serotype 2 activity and mode of action of a novel peptide","volume":"119","author":"Chew","year":"2015","journal-title":"J. Appl. Microbiol."},{"issue":"1","key":"10.1016\/j.virusres.2021.198456_bib0025","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1186\/s12879-015-1195-2","article-title":"Risk factors for severe hand foot mouth disease in Singapore: a case control study","volume":"15","author":"Chew","year":"2015","journal-title":"BMC Infect. Dis."},{"issue":"8","key":"10.1016\/j.virusres.2021.198456_bib0030","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/01.inf.0000133045.45316.6a","article-title":"Long term tolerability and safety of enfuvirtide for human immunodeficiency virus 1-infected children","volume":"23","author":"Church","year":"2004","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"1","key":"10.1016\/j.virusres.2021.198456_bib0035","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1208\/s12248-014-9687-3","article-title":"Strategic approaches to optimizing peptide ADME properties","volume":"17","author":"Di","year":"2015","journal-title":"AAPS J."},{"issue":"1","key":"10.1016\/j.virusres.2021.198456_bib0040","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.drudis.2014.10.003","article-title":"Peptide therapeutics: current status and future directions","volume":"20","author":"Fosgerau","year":"2015","journal-title":"Drug Discov. Today"},{"issue":"4","key":"10.1016\/j.virusres.2021.198456_bib0045","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2217\/fvl-2016-0144","article-title":"Identifying novel antiviral targets against enterovirus 71: where are we?","volume":"12","author":"Gunaseelan","year":"2017","journal-title":"Future Virol."},{"issue":"12","key":"10.1016\/j.virusres.2021.198456_bib0050","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.1128\/AAC.47.12.3907-3916.2003","article-title":"Phase II, randomized, double-blind, placebo-controlled studies of ruprintrivir nasal spray 2-percent suspension for prevention and treatment of experimentally induced rhinovirus colds in healthy volunteers","volume":"47","author":"Hayden","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.virusres.2021.198456_bib0055","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1021\/acs.jmedchem.7b00318","article-title":"The current state of peptide drug discovery: back to the future?","volume":"61","author":"Henninot","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.virusres.2021.198456_bib0060","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.addr.2018.07.011","article-title":"Harnessing albumin as a carrier for cancer therapies","volume":"130","author":"Hoogenboezem","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.virusres.2021.198456_bib0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017213","article-title":"Age-related differences in plasma proteins: how plasma proteins change from neonates to adults","volume":"6","author":"Ignjatovic","year":"2011","journal-title":"PLoS One"},{"issue":"14","key":"10.1016\/j.virusres.2021.198456_bib0070","doi-asserted-by":"crossref","first-page":"5801","DOI":"10.1073\/pnas.0901007106","article-title":"Addition of a cholesterol group to an HIV-1 peptide fusion inhibitor dramatically increases its antiviral potency","volume":"106","author":"Ingallinella","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.virusres.2021.198456_bib0075","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1128\/AAC.01428-10","article-title":"Identification of the minimal active sequence of an anti-influenza virus peptide","volume":"55","author":"Jones","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virusres.2021.198456_bib0080","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.antiviral.2015.10.006","article-title":"Potent antiviral agents fail to elicit genetically-stable resistance mutations in either enterovirus 71 or Coxsackievirus A16","volume":"124","author":"Kelly","year":"2015","journal-title":"Antiviral Res."},{"issue":"7","key":"10.1016\/j.virusres.2021.198456_bib0085","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1017\/S0950268815002630","article-title":"A dynamic model for the outbreaks of hand, foot, and mouth disease in Taiwan","volume":"144","author":"Lai","year":"2016","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.virusres.2021.198456_bib0090","article-title":"Therapeutic peptides: historical perspectives, current development trends, and future directions","author":"Lau","year":"2017","journal-title":"Bioorg. Med. Chem."},{"issue":"21","key":"10.1016\/j.virusres.2021.198456_bib0095","doi-asserted-by":"crossref","first-page":"15616","DOI":"10.18632\/oncotarget.24582","article-title":"New antimicrobial peptide kills drug-resistant pathogens without detectable resistance","volume":"9","author":"Lee","year":"2018","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.virusres.2021.198456_bib0100","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3201\/eid0903.020285","article-title":"Enterovirus 71 outbreaks, Taiwan: occurrence and recognition","volume":"9","author":"Lin","year":"2003","journal-title":"Emerg. Infect. Dis."},{"issue":"1","key":"10.1016\/j.virusres.2021.198456_bib0105","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1142\/S0192415X09006734","article-title":"Anti-enterovirus 71 activity screening of chinese herbs with anti-infection and inflammation activities","volume":"37","author":"Lin","year":"2009","journal-title":"Am. J. Chin. Med."},{"issue":"8","key":"10.1016\/j.virusres.2021.198456_bib0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135503","article-title":"Clinical features for mild hand, foot and mouth disease in China","volume":"10","author":"Liu","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.virusres.2021.198456_bib0115","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1574-6976.2002.tb00601.x","article-title":"An overview of the evolution of enterovirus 71 and its clinical and public health significance","volume":"26","author":"McMinn","year":"2002","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.virusres.2021.198456_bib0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.dib.2019.103868","article-title":"Compendium of hand, foot and mouth disease data in Malaysia from years 2010\u20132017","volume":"24","author":"Nelson","year":"2019","journal-title":"Data Brief"},{"issue":"9","key":"10.1016\/j.virusres.2021.198456_bib0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012684","article-title":"Serum stabilities of short tryptophan- and arginine-rich antimicrobial peptide analogs","volume":"5","author":"Nguyen","year":"2010","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.virusres.2021.198456_bib0130","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofz284","article-title":"Economic burden attributed to children presenting to hospitals with hand, foot, and mouth disease in Vietnam","volume":"6","author":"Nhan","year":"2019","journal-title":"Open Forum Infect. Dis."},{"issue":"3","key":"10.1016\/j.virusres.2021.198456_bib0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004562","article-title":"Cyclical patterns of hand, foot and mouth disease caused by Enterovirus A71 in Malaysia","volume":"10","author":"NikNadia","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.virusres.2021.198456_bib0140","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01366","article-title":"Peptide antiviral strategies as an alternative to treat lower respiratory viral infections","volume":"10","author":"Nyanguile","year":"2019","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.virusres.2021.198456_bib0145","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.2165\/00003495-200565080-00007","article-title":"Enfuvirtide: a review of its use in the management of HIV infection","volume":"65","author":"Oldfield","year":"2005","journal-title":"Drugs"},{"issue":"11","key":"10.1016\/j.virusres.2021.198456_bib0150","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S1474-4422(10)70209-X","article-title":"Clinical features, diagnosis, and management of enterovirus 71","volume":"9","author":"Ooi","year":"2010","journal-title":"Lancet Neurol."},{"issue":"9","key":"10.1016\/j.virusres.2021.198456_bib0155","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1023\/A:1018953309913","article-title":"Peptide stability in drug development. II. Effect of single amino acid substitution and glycosylation on peptide reactivity in human serum","volume":"10","author":"Powell","year":"1993","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.virusres.2021.198456_bib0160","doi-asserted-by":"crossref","first-page":"11662","DOI":"10.1038\/s41598-019-48259-1","article-title":"The clinical and epidemiological study of children with hand, foot, and mouth disease in Hunan, China from 2013 to 2017","volume":"9","author":"Qiu","year":"2019","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.virusres.2021.198456_bib0165","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1021\/jm010536a","article-title":"Design, synthesis, and structure-activity relationship of pyridyl imidazolidinones: a novel class of potent and selective human enterovirus 71 inhibitors","volume":"45","author":"Shia","year":"2002","journal-title":"J. Med. Chem."},{"issue":"14","key":"10.1016\/j.virusres.2021.198456_bib0170","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1021\/jm0703542","article-title":"Albumin binding of short cationic antimicrobial micropeptides and its influence on the in vitro bactericidal effect","volume":"50","author":"Svenson","year":"2007","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.virusres.2021.198456_bib0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034589","article-title":"Inhibition of enterovirus 71 (EV-71) infections by a novel antiviral peptide derived from EV-71 capsid protein VP1","volume":"7","author":"Tan","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.virusres.2021.198456_bib0180","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1423-0127-21-14","article-title":"Recent developments in antiviral agents against enterovirus 71 infection","volume":"21","author":"Tan","year":"2014","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.virusres.2021.198456_bib0185","doi-asserted-by":"crossref","first-page":"33663","DOI":"10.1038\/srep33663","article-title":"Antiviral activities of peptide-based covalent inhibitors of the Enterovirus 71 3C protease","volume":"6","author":"Tan","year":"2016","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.virusres.2021.198456_bib0190","doi-asserted-by":"crossref","first-page":"4529","DOI":"10.3390\/v7082832","article-title":"Replication and inhibitors of enteroviruses and parechoviruses","volume":"7","author":"van der Linden","year":"2015","journal-title":"Viruses"},{"issue":"3","key":"10.1016\/j.virusres.2021.198456_bib0195","doi-asserted-by":"crossref","first-page":"510","DOI":"10.5114\/aoms.2014.43745","article-title":"Clinical features of severe cases of hand, foot and mouth disease with EV71 virus infection in China","volume":"10","author":"Wang","year":"2014","journal-title":"Arch. Med. Sci.: AMS"},{"issue":"9","key":"10.1016\/j.virusres.2021.198456_bib0200","doi-asserted-by":"crossref","first-page":"5357","DOI":"10.1128\/AAC.01073-16","article-title":"In vitro assessment of combinations of enterovirus inhibitors against Enterovirus 71","volume":"60","author":"Wang","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"issue":"21","key":"10.1016\/j.virusres.2021.198456_bib0205","doi-asserted-by":"crossref","first-page":"9770","DOI":"10.1073\/pnas.91.21.9770","article-title":"Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection","volume":"91","author":"Wild","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.virusres.2021.198456_bib0210","doi-asserted-by":"crossref","first-page":"514","DOI":"10.2174\/0929866525666180530122835","article-title":"Optimization of protein and peptide drugs based on the mechanisms of kidney clearance","volume":"25","author":"Wu","year":"2018","journal-title":"Protein Pept. Lett."},{"issue":"12","key":"10.1016\/j.virusres.2021.198456_bib0215","doi-asserted-by":"crossref","first-page":"e1076","DOI":"10.1016\/j.ijid.2010.07.006","article-title":"The largest outbreak of hand; foot and mouth disease in Singapore in 2008: the role of enterovirus 71 and coxsackievirus A strains","volume":"14","author":"Wu","year":"2010","journal-title":"Int. J. Infect. Dis."},{"issue":"4","key":"10.1016\/j.virusres.2021.198456_bib0220","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00705-011-1222-6","article-title":"In vitro and in vivo evaluation of ribavirin and pleconaril antiviral activity against enterovirus 71 infection","volume":"157","author":"Zhang","year":"2012","journal-title":"Arch. Virol."},{"issue":"5","key":"10.1016\/j.virusres.2021.198456_bib0225","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.bjid.2012.08.001","article-title":"Etiologic and epidemiologic analysis of hand, foot, and mouth disease in Guangzhou city: a review of 4,753 cases","volume":"16","author":"Zou","year":"2012","journal-title":"Braz. J. Infect. Dis."}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170221001635?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170221001635?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T14:13:59Z","timestamp":1759155239000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168170221001635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":45,"alternative-id":["S0168170221001635"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2021.198456","relation":{},"ISSN":["0168-1702"],"issn-type":[{"value":"0168-1702","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stability and antiviral activity of SP40 peptide in human serum","name":"articletitle","label":"Article Title"},{"value":"Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virusres.2021.198456","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"198456"}}